Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             64 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of Barrett’s oesophagus in pernicious anaemia: acid is not the only culprit! Carabotti, Marilia
2016
3 p. 419-421
artikel
2 Accuracy and safety of second-generation PillCam COLON capsule for colorectal polyp detection Spada, Cristiano
2012
3 p. 173-178
artikel
3 Acknowledgements 2008
3 p. 201-201
artikel
4 Acute pancreatitis secondary to hemobilia after percutaneous liver biopsy Peña, Luis R.
2009
3 p. 165-168
artikel
5 Adopting new enrollment criteria for pharmaceutical trials in constipation: look before leaping Whitehead, William E.
2011
3 p. 165-168
artikel
6 Assessing the risks and benefits of treating Helicobacter pylori infection Hung, Ivan F.N.
2009
3 p. 141-147
artikel
7 Autoimmune diseases in coeliac disease: effect of gluten exposure Ouaka-Kchaou, Asma
2008
3 p. 169-172
artikel
8 Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection Kwo, Paul Y.
2012
3 p. 179-188
artikel
9 Bowel preparation regimens for colon capsule endoscopy: a review Singhal, Shashideep
2014
3 p. 115-122
artikel
10 Cannulation of the biliary tree under endoscopic control with an echoendoscope, without fluoroscopy: report of a case series Arcidiacono, Paolo Giorgio
2015
3 p. 121-124
artikel
11 Chronic appendicitis: uncommon cause of chronic abdominal pain Kothadia, Jiten P.
2015
3 p. 160-162
artikel
12 Clinical experience with infliximab biosimilar Remsima (CT-P13) in inflammatory bowel disease patients Jahnsen, Jørgen
2016
3 p. 322-329
artikel
13 Coffee, caffeine and non-alcoholic fatty liver disease? Kennedy, Oliver John
2016
3 p. 417-418
artikel
14 Colonoscopy and colorectal cancer mortality: both sides of the story Neugut, Alfred I.
2013
3 p. 189-191
artikel
15 Current and future role of magnetically assisted gastric capsule endoscopy in the upper gastrointestinal tract Ching, Hey-Long
2016
3 p. 313-321
artikel
16 Diagnosis and management of iron deficiency anemia in the 21st century Johnson-Wimbley, Terri D.
2011
3 p. 177-184
artikel
17 Drug-eluting beads in hepatocellular carcinoma Abe, Hiroyuki
2017
3 p. 337-338
artikel
18 Early ‘shallow’ needle-knife papillotomy and guidewire cannulation: an effective and safe approach to difficult papilla Fiocca, Fausto
2015
3 p. 114-120
artikel
19 Effective treatment of chronic radiation proctitis using radiofrequency ablation Chao Zhou,
2009
3 p. 149-156
artikel
20 Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis Clavé, Pere
2017
3 p. 311-322
artikel
21 Endoscopic approach to subepithelial lesions Menon, Laila
2014
3 p. 123-130
artikel
22 EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence Onda, Saori
2016
3 p. 302-312
artikel
23 Fecal microbiota transplant for Clostridium difficile infection in older adults Tauxe, William M.
2016
3 p. 273-281
artikel
24 From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn’s disease Randall, Charles W.
2015
3 p. 143-159
artikel
25 Health resource utilization and multidisciplinary impact of endoscopic ultrasonography in a tertiary referral medical center Sodikoff, Jamie B.
2013
3 p. 199-203
artikel
26 Hemostatic powder spray: a new method for managing gastrointestinal bleeding Changela, Kinesh
2015
3 p. 125-135
artikel
27 How should we classify and treat patients with functional gastrointestinal disorders? McLaughlin, John T.
2008
3 p. 153-156
artikel
28 Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation Camilleri, Michael
2011
3 p. 159-163
artikel
29 Insights into the genetic risk factors for the development of pancreatic disease Zator, Zachary
2017
3 p. 323-336
artikel
30 Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials Zelber-Sagi, Shira
2016
3 p. 392-407
artikel
31 Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Sobhani, Iradj
2013
3 p. 215-229
artikel
32 New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists Foxx-Orenstein, Amy E.
2016
3 p. 354-375
artikel
33 New strategies for the management of diverticular disease: insights for the clinician Boynton, Wen
2013
3 p. 205-213
artikel
34 Novel bile acid therapeutics for the treatment of chronic liver diseases Hegade, Vinod S.
2016
3 p. 376-391
artikel
35 Nutritional management of Crohn’s disease Donnellan, Clare F.
2013
3 p. 231-242
artikel
36 Perception of colorectal cancer risk does not enhance participation in screening Dear, Keith
2008
3 p. 157-167
artikel
37 Pillcam ESO® is more accurate than clinical scoring systems in risk stratifying emergency room patients with acute upper gastrointestinal bleeding Gutkin, Ellen
2013
3 p. 193-198
artikel
38 Predictors for postoperative esophageal stricture after balloon-based radiofrequency ablation for early esophageal squamous neoplasia: a multicenter validation study Wang, Wen-Lun
2016
3 p. 257-264
artikel
39 Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease Touzin, Nadege T.
2011
3 p. 169-176
artikel
40 Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection Hickson, Mary
2011
3 p. 185-197
artikel
41 Refining small intestinal bacterial overgrowth diagnosis by means of carbohydrate specificity: a proof-of-concept study Enko, Dietmar
2016
3 p. 265-272
artikel
42 Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective Shale, Matt
2010
3 p. 173-177
artikel
43 Review: Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia Kinoshita, Yoshikazu
2008
3 p. 191-199
artikel
44 Review: Functional dyspepsia Brun, Rita
2010
3 p. 145-164
artikel
45 Review: New direct-acting antivirals in the development for hepatitis C virus infection Pockros, Paul J.
2010
3 p. 191-202
artikel
46 Review: Optimal use of biologics in the management of Crohn’s disease Panaccione, Remo
2010
3 p. 179-189
artikel
47 Review: Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome Lucak, Susan L.
2010
3 p. 165-172
artikel
48 Review: Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome Gaman, Alexandru
2009
3 p. 169-181
artikel
49 Review: Treatment options for nonalcoholic fatty liver disease Chitturi, Shivakumar
2008
3 p. 173-189
artikel
50 Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence Flamm, Steven L.
2011
3 p. 199-206
artikel
51 Salvage therapy using self-expandable metal stents for recalcitrant anastomotic strictures after living-donor liver transplantation Jang, Sung Ill
2017
3 p. 297-309
artikel
52 Secondary causes of nonalcoholic fatty liver disease Kneeman, Jacob M.
2012
3 p. 199-207
artikel
53 Small bowel stricture characterization and outcomes of dilatation by double-balloon enteroscopy: a single-centre experience Gill, Raghubinder S.
2014
3 p. 108-114
artikel
54 Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential Stedman, Catherine
2014
3 p. 131-140
artikel
55 Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome Jeppesen, Palle Bekker
2012
3 p. 159-171
artikel
56 The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D) Min, Yang Won
2015
3 p. 136-142
artikel
57 The continuing dilemma of chronic appendicitis Whorwell, Peter J.
2015
3 p. 112-113
artikel
58 The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial Shields, William W.
2009
3 p. 157-163
artikel
59 The new kid on the block for advanced imaging in Barrett’s esophagus: a review of volumetric laser endomicroscopy Trindade, Arvind J.
2016
3 p. 408-416
artikel
60 The role of vedolizumab in patients with moderate-to-severe Crohn’s disease and ulcerative colitis Shahidi, Neal
2016
3 p. 330-338
artikel
61 Ulcerative colitis, infliximab, and hepatic epithelioid hemangioendothelioma: who is to blame? Case Report Chang, Joseph Y.
2010
3 p. 203-206
artikel
62 Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia Habib, Shahid
2012
3 p. 189-197
artikel
63 What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans Fragkos, Konstantinos C.
2016
3 p. 282-301
artikel
64 What goes around comes around: novel pharmacological targets in the gut–brain axis González-Arancibia, Camila
2016
3 p. 339-353
artikel
                             64 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland